Evidence map›Paper›PMID 41923049›Full record

ArticleBMC medical genomics2026

A novel homozygous splicing variant in FREM1 expands the phenotypic spectrum of BNAR syndrome: functional validation and successful PGT-M.

Lulu Yan, Yingwen Liu, Yuxin Zhang, Chunxiao Han, Juan Cao, Jinghui Zou, Hongjing Luo, Haibo Li

Abstract read
In one paragraph

Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lulu YanThe Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, 315000, China.
Yingwen LiuThe Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, 315000, China.
Yuxin ZhangThe Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, 315000, China.
Chunxiao HanThe Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, 315000, China.
Juan CaoDepartment of Obstetrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, 315000, China.
Jinghui ZouDepartment of Obstetrics, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, 315000, China.
Hongjing LuoDepartment of Obstetrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, 315000, China.
Haibo LiThe Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, 315000, China. lihaibo-775@163.com.

Funding

Innovation Project of Distinguished Medical Team in Ningbo Grant No. 2022020405Key Technology Breakthrough Program of Ningbo Sci-Tech Innovation YONGJIANG 2035 Grant No. 2024Z221Natural Science Foundation of Ningbo Municipality Grant No. 2024J358Ningbo science and technology project Grant No. 2023Z178
6 · The paper itself

Abstract

backgroundBifid nose with or without anorectal and renal anomalies (BNAR) is a rare autosomal recessive genetic congenital disorder characterized by bifid nose and renal agenesis, with or without anorectal malformations. Our research identified the genetic factors associated with BNAR in a Chinese pedigree.

methodsMuscle tissue specimens from the fetus and peripheral blood specimens from the parents were collected, and genomic DNA was extracted for whole-exome sequencing. Sanger sequencing was used to verify the emergence of variants in the pedigree. Minigene assays and structural modeling were performed to confirm the influence of intronic variants on mRNA splicing.

resultsWe identified a homozygous splicing variant, c.3274 + 4 A > G, in the FREM1 gene in the fetus. Sanger sequencing revealed that the parents were heterozygous. In vitro and in intro minigene assays revealed exon 18 skipping, causing a nonframeshift, 62 amino acid deletion in FREM1. Structural predictions indicate the deletion severely disrupts the FREM1 CSPG6 domain, replacing its stable interwoven β-sheet architecture with a single β-sheet and an aberrant α-helix. This profound conformational shift likely abolishes the interaction interfaces required for FRAS1/FREM multiprotein complex assembly, impairing its overall function. Based on these findings, the variant was categorized as likely pathogenic according to the American College of Medical Genetics and Genomics guidelines. Accordingly, after being informed about the hazards of the pathogenic variant, the couple selected preimplantation genetic tests for monogenic disorders (PGT-M) and had a healthy baby.

conclusionThis study presents a Chinese fetus with FREM1-related pathology. Moreover, this study extends the phenotypic spectrum of BNAR, while laying a foundation for PGT-M.

Indexed as

HomozygoteKidneyKidney DiseasesReceptors, InterleukinRNA SplicingCongenital AbnormalitiesExome SequencingFemaleHumansMaleModels, MolecularPedigreePhenotypeFrem1 protein, humanReceptors, InterleukinBifid nose with or without anorectal and renal anomaliesFREM1 geneMinigene assaySplicing VariantWhole exome sequencing

Identifiers

PMID41923049
PMCPMC13188615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.